| Financial Year |
March 31 2023 |
| Monetary Funds |
7,178,613,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
27,827,000.00 |
| Accounts Receivable |
12,696,754,000.00 |
| Advances to Suppliers |
3,679,600,000.00 |
| Other Receivables |
884,803,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
335,506,000.00 |
| Inventories |
2,964,870,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
96,552,000.00 |
| Other Current Assets |
1,366,422,000.00 |
| Total Current Assets |
29,742,162,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,204,726,000.00 |
| Investment Properties |
70,723,000.00 |
| Fixed Assetes |
123,369,602,000.00 |
| Under-construction Projects |
15,545,026,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,360,011,000.00 |
| R&D expenses |
-- |
| Goodwill |
373,940,000.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,728,787,000.00 |
| Other Non-Current Assets |
566,578,000.00 |
| Sub-Total of Non-Current Assets |
193,424,070,000.00 |
| Total Assets |
223,166,232,000.00 |
| Short-Term Loans |
22,820,318,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,232,531,000.00 |
| Accounts Payable |
12,382,279,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
369,491,000.00 |
| Taxes Payable |
992,923,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
137,892,000.00 |
| Other payables |
2,472,420,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,939,954,000.00 |
| Other Current Liabilities |
54,068,000.00 |
| Sub-Total of Current Liabilities |
50,841,892,000.00 |
| Long-term Loans |
67,564,091,000.00 |
| Bonds Payable |
24,942,333,000.00 |
| Long-Term Accounts Payable |
69,542,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
63,400,000.00 |
| Deferred Income Tax Liabilities |
860,577,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
97,410,459,000.00 |
| Total Liabilities |
148,252,351,000.00 |
| Paid-In Capital(Or Share Stock) |
9,893,710,000.00 |
| Capital Surplus |
13,034,860,000.00 |
| Surplus Reserve |
4,653,035,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,011,804,000.00 |
| Minority Stockholder's Interest |
11,069,147,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
63,844,734,000.00 |
| Owner's Equity（Stockholder's Equity） |
74,913,881,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
223,166,232,000.00 |
